Assessing the non-cancer risk for RDX (hexahydro-1,3,5-trinitro-1,3,5-triazine) using physiologically based pharmacokinetic (PBPK) modeling
| Autor: | Sweeney, Lisa M., Gut, Chester P., Jr., Gargas, Michael L., Reddy, Gunda, Williams, Larry R., Johnson, Mark S. |
|---|---|
| Zdroj: | In Regulatory Toxicology and Pharmacology February 2012 62(1):107-114 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect